Clinical Trial Update: The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders

View source ↗

Summary

An observational ClinicalTrials.gov update (RITAI Cohort) investigates off-label use of rituximab for autoimmune disorders, including pemphigus, immune thromboc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hemolytic Anemia
• Cold Agglutinin Disease
• Cryoglobulinemia
• Immune Thrombocytopenia
• Pemphigus

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Pemphigus, Auto-immune Thrombocytopenic Purpura | Status: COMPLETED